Skip to main content

Thoughts on the infectious aetiology of primary biliary cirrhosis

  • Chapter
Immunology and Liver

Part of the book series: Falk Symposium ((FASS,volume 114))

Abstract

Primary biliary cirrhosis (PBC) is characterized by features consistent with autoimmune aetiological mechanisms. However, the initiating events in autoimmunity, by which tolerance to self-antigens is broken, are still poorly understood. Indeed, as will be considered, characteristic features of infection and autoimmunity are not mutually exclusive. Recent reports increasingly lend support to earlier speculation and hypotheses that proposed involvement of infectious agents in aetiological mechanisms in autoimmunity. Conversely, autoimmune phenomena are associated with certain infections. It has long been suggested that some features of PBC may have more in common with a response to infection than an autoimmune reaction. Evidence for involvement of an infectious agent in the aetiology of PBC will be considered in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. James OFW. Definition and epidemiology of primary biliary cirrhosis. In: Neuberger JM, editor. Primary Biliary Cirrhosis. Eastbourne, UK: West End Studios; 1999:53–59.

    Google Scholar 

  2. Anand AC, Elias E, Neuberger JM. End-stage primary biliary cirrhosis in a first generation migrant South Asian population. Eur J Gastroenterol Hepatol. 1996;7:663–666.

    Google Scholar 

  3. Triger DR. Primary biliary cirrhosis: an epidemiological study. Br Med J. 1984;281:772–775.

    Article  Google Scholar 

  4. Agarwal K, Jones DEJ, Bassendine MF. Genetic susceptibility to primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 1999;11:603–606.

    Article  PubMed  CAS  Google Scholar 

  5. Fussey SPM, Guest JR, James OFW et al. Identification and analysis of the major M2 autoantigens in PBC. Proc Natl Acad Sci USA. 1988;85:8654–8658.

    Article  PubMed  CAS  Google Scholar 

  6. Coppell RL, McNeilage J, Surh CD et al. Primary structure of the human M2 mitochondrial autoantigen of PBC: dihydrolipoamide acteyltransferase. Proc Natl Acad Sci USA. 1988;85:7317–7321.

    Article  Google Scholar 

  7. Leung PSC, Van de Water J, Coppel RL et al. Molecular characterisation of the mitochondrial autoantigens in primary biliary cirrhosis. Immunol Res 1991;10:518–543.

    Article  PubMed  CAS  Google Scholar 

  8. Joplin R, Johnson GD, Matthews JB et al. Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis. Hepatol. 1994;19:1375–1380.

    Article  CAS  Google Scholar 

  9. Joplin R, Wallace LL, Johnson GD et al. Subcellular localisation of pyruvate dheydrogenase dihydrolipoamide acetyltransferase in human intrahepatic biliary epithelial cells. J Pathol. 1995;176:381–390.

    Article  PubMed  CAS  Google Scholar 

  10. Van de Water J, Ansari AA, Surh CD et al. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T-cell response of primary biliary cirrhosis. J Immunol. 1991;146:89–94.

    PubMed  Google Scholar 

  11. Joplin R, Wallace LL, Lindsay JG et al. The human biliary epithelial cell plasma membrane antigen in primary biliary cirrhosis: pyruvate dehydrogenase X? Gastroenterology. 1997;113:1727–1733.

    Article  PubMed  CAS  Google Scholar 

  12. Ayres RCS, Neuberger JM, Shaw J et al. Intercellular-adhesion molecule and MHC antigens on human intrahepatic bile-duct cells-effect of pro-inflammatory cytokines. Gut. 1993;9:1245–1249.

    Article  Google Scholar 

  13. Saidman S, Duquesnoy RJ, Zeevi A et al. Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology. 1991;13:239–246.

    Article  PubMed  CAS  Google Scholar 

  14. Grotzinger T, Sternsdorf T, Jensen K, Will H. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur J Biochem. 1996;238:554–560.

    Article  PubMed  CAS  Google Scholar 

  15. Harada K, Van de Water J, Leung PSC et al. In situnucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology. 1997;25:791–796.

    Article  PubMed  CAS  Google Scholar 

  16. Shindo M, Mullin G, Braun-Elwert L et al. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clin Exp Immunol. 1996;105:254–259.

    Article  PubMed  CAS  Google Scholar 

  17. Ascher NL. The role of the host immune state in recurrent hepatitis C. Liver Transplant Surg. 1997;3:179–180.

    Article  CAS  Google Scholar 

  18. Sadamoto T, Neuberger JM, Joplin R. Effect of pro-inflammatory cytokines on human biliary epithelial cells (BEC): interleukin-1 up-regulates pyruvate dehydrogenase E2/X (PDC-E2/X). Hepatology. 1997;26:1264 (abstract).

    Google Scholar 

  19. Leuschner U. Medical treatment of vanishing bile duct syndrome. In: Alvaro D, Benedetti A, Strazzabosco M. editors. Vanishing Bile Duct Syndrome. Pathophysiology and Treatment. Lancaster: Kluwer; 1997;213–223.

    Google Scholar 

  20. Neuberger JM. Primary biliary cirrhosis transplantation and recurrent disease. In: Lindor KD, Heathcote JE, Poupon R, editors. Primary Biliary Cirrhosis: from Pathogenesis to Clinical Treatment. Lancaster: Kluwer; 1998:155–161.

    Google Scholar 

  21. Dmetrewski J, Mayer AD, Hubscher SG et al. Histological recurrence of primary biliary cirrhosis after liver transplantation: effect of immunosuppresssion. J Hepatol. 1996;24:253–257.

    Article  Google Scholar 

  22. Van de Water J, Gerson LB, Ferrell LD et al. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology. 1996;24:1079–1084.

    Article  PubMed  Google Scholar 

  23. Jones DEJ, Watt FE, Metcalf JV et al. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol. 1999;30:402–407.

    Article  PubMed  CAS  Google Scholar 

  24. Delpre G, Niv Y. Primary biliary cirrhosis occurring in a married couple. J Hepatol. 1998;28:232 (abstract).

    Article  Google Scholar 

  25. Sadomoto T, Joplin R, Keogh A et al. Expression of pyruvate dehydrogenase complex E2 on normal biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis. Lancet. 1998;352:1595–1596.

    Article  Google Scholar 

  26. Klein R, Wiebel M, Engelhart S et al. Sera from patients with tuberculosis recognise the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis. Clin Exp Immunol. 1993;92:308–316.

    Article  PubMed  CAS  Google Scholar 

  27. Vilagut L, Vila J, Pares A et al. Cross-reactivity of anti-mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol. 1994;21:673–677.

    Article  PubMed  CAS  Google Scholar 

  28. O’Donohue J, Fiddler H, Garcia-Barcelo M et al. Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis. J Hepatol. 1998;28:433–438.

    Article  PubMed  Google Scholar 

  29. Hopf U, Stemerowicz R, Rodloff A et al. Relation between Escherichia coliR (rough)-forms in gut, lipid A and primary biliary cirrhosis. Lancet. 1989;2:1421–1422.

    Google Scholar 

  30. Butler P, Valle F, Hamilton-Miller J et al. M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and recurrent bacteriuria. J Hepatol. 1993;17:408–414.

    Article  PubMed  CAS  Google Scholar 

  31. O’Donohue J, Workman MR, Rolando N et al. Urinary tract infections in primary biliary cirrhosis and other chronic liver diseases. Eur J Clin Microbiol Infect Dis. 1997;16:743–746.

    Article  PubMed  Google Scholar 

  32. Nickowitz RE, Worman HJ. Autoantibodies from patients with primary biliary cirrhosis recognise a restricted region within the cytoplasmic tail of nuclear-pore membrane glycoprotein gp210. J Exp Med. 1993;6:2237–2242.

    Article  Google Scholar 

  33. Fussey SPM, Lindsay JG, Fuller C et al. Autoantibodies in primary biliary cirrhosis-analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes. Hepatology. 1991;13:467–474.

    Article  PubMed  CAS  Google Scholar 

  34. Teoh KL, Mackay IR, Rowley MJ et al. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry. Hepatology. 1994;19:1029–1033.

    Article  PubMed  CAS  Google Scholar 

  35. Howell CD, Li J, Chen W. Animal models of primary biliary cirrhosis. In: Lindor KD, Heathcote JE, Poupon R, editors. Primary Biliary Cirrhosis: from Pathogenesis to Clinical Treatment. Lancaster: Kluwer; 1998;53–63.

    Chapter  Google Scholar 

  36. Hyoty H, Hilttunen M, Lonnrot M. Enterovirus infections and insulin dependent diabetes mellitus-evidence for causality. Clin Diagnostic Virol. 1998;9:77–84.

    Article  CAS  Google Scholar 

  37. Andreoletti L, Hober D, Heber-Vandenberghe C et al. Coxsackie B virus infection and beta cell autoantibodies in newly diagnosed IDDM adult patients. Clin Diagnostic Virol. 1998; 9:125–133.

    Article  CAS  Google Scholar 

  38. Sekigawa I, Kaneko H, Hishikawa T et al. HIV infection and SLE: their pathogenic relationship. Clin Exp Rheumatol. 1998;6:175–180.

    Google Scholar 

  39. Mason AL, Xu LZ, Guo LS et al. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet. 1998;351:1620–1624.

    Article  PubMed  CAS  Google Scholar 

  40. Xu L, Guo L, Joplin R et al. A viral etiology of primary biliary cirrhosis. Hepatology. 1997;26:1250 (abstract).

    Article  Google Scholar 

  41. Joplin R, Neuberger JM. Immunopathology of primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 1999;11:587–593.

    Article  PubMed  CAS  Google Scholar 

  42. Picker LJ, Treer JR, Ferguson-Darnell JR et al. Control of lymphocyte recirculation in man. Differential regulation of peripheral lymph node homing receptor L-selectin on T-cells during virgin to memory transition. J Immunol. 1993; 150:1105–1121.

    PubMed  CAS  Google Scholar 

  43. Leon MP, Spickett G, Jones DEJ et al. CD4+ T-cell subsets defined by isoforms of CD45 in primary biliary cirrhosis. Clin Exp Immunol. 1995;99:233–239.

    Article  PubMed  CAS  Google Scholar 

  44. Joplin R, Lindsay JG, Hubscher SG et al. Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study. Hepatology. 1991;14:442–447.

    Article  PubMed  CAS  Google Scholar 

  45. Leon MP, Bassendine MF, Wilson JL et al. Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T-cells. Hepatology. 1996;24:561–567.

    Article  PubMed  CAS  Google Scholar 

  46. Jones DEJ, Palmer JM, Yeaman SJ et al. T-cell responses to native human proteins in primary biliary cirrhosis. Clin Exp Immunol. 1997;107:562–568.

    Article  PubMed  CAS  Google Scholar 

  47. Van de Water J, Ansari A, Prindiville T et al. Heterogeneity of autoreactive T-cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med. 1995;181:723–733.

    Article  PubMed  Google Scholar 

  48. Shimoda S, Nakamura M, Ishibishi H et al. HLA DRB4 0101-restricted immunodominant T-cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune disease. J Exp Med. 1995;181:1835–1845.

    Article  PubMed  CAS  Google Scholar 

  49. Anderson KL, Anderson G, Michell RH et al. Intracellular signalling pathways involved in the induction of apoptosis in immature thymic T-lymphocytes. J Immunol. 1996; 11:4083–4091.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Joplin, R. (2000). Thoughts on the infectious aetiology of primary biliary cirrhosis. In: Manns, M.P., Paumgartner, G., Leuschner, U. (eds) Immunology and Liver. Falk Symposium, vol 114. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4000-3_23

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4000-3_23

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5768-4

  • Online ISBN: 978-94-011-4000-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics